104 related articles for article (PubMed ID: 24409670)
1. Combining cortactin and CTTN detection with clinicopathologic features increases effectiveness of survival predictions for patients with resectable hepatocellular carcinoma.
Gang Z; Ya-Lin K; Dong-Qing W; Yu L; Li R; Hong-Yi Z
Clin Lab; 2013; 59(11-12):1343-52. PubMed ID: 24409670
[TBL] [Abstract][Full Text] [Related]
2. Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.
Zhao G; Huang ZM; Kong YL; Wen DQ; Li Y; Ren L; Zhang HY
World J Surg Oncol; 2013 Mar; 11():74. PubMed ID: 23518204
[TBL] [Abstract][Full Text] [Related]
3. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival.
Folio C; Zalacain M; Zandueta C; Ormazábal C; Sierrasesúmaga L; San Julián M; de las Rivas J; Toledo G; Lecanda F; Patiño-García A
Cancer Biomark; 2011-2012; 10(1):35-41. PubMed ID: 22297550
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.
Zhao G; Zhang H; Huang Z; Lv L; Yan F
Mol Biol Rep; 2016 May; 43(5):407-14. PubMed ID: 27025610
[TBL] [Abstract][Full Text] [Related]
6. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
7. Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma.
Huang X; Ji J; Xue H; Zhang F; Han X; Cai Y; Zhang J; Ji G
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):633-9. PubMed ID: 22495401
[TBL] [Abstract][Full Text] [Related]
8. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
10. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
[TBL] [Abstract][Full Text] [Related]
11. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis.
Li G; Yuan L; Liu D; Liu J
Technol Cancer Res Treat; 2016 Jun; 15(3):517-22. PubMed ID: 26031464
[TBL] [Abstract][Full Text] [Related]
13. Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
Tsai TJ; Chao WY; Chen CC; Chen YJ; Lin CY; Lee YR
Anticancer Res; 2018 Jul; 38(7):3943-3950. PubMed ID: 29970516
[TBL] [Abstract][Full Text] [Related]
14. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients.
Li SL; Su M; Peng T; Xiao KY; Shang LM; Xu BH; Su ZX; Ye XP; Peng N; Qin QL; Chen DF; Chen J; Li LQ
Asian Pac J Cancer Prev; 2013; 14(1):217-23. PubMed ID: 23534727
[TBL] [Abstract][Full Text] [Related]
16. The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.
Zhu L; Cho E; Zhao G; Roh MR; Zheng Z
In Vivo; 2019; 33(2):393-400. PubMed ID: 30804117
[TBL] [Abstract][Full Text] [Related]
17. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
19. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
